Cubist Systematic Strategies’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Cubist Systematic Strategies’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-629,218	Closed	-$6.32M	–	4706
2022 Q4	$6.32M	Sell	629,218 -5,004	-0.8%	-$49.8K	0.04%	817
2022 Q3	$6.24M	Sell	634,222 -146	-0%	-$1.43K	0.04%	859
2022 Q2	$6.18M	Sell	634,368 -530	-0.1%	-$5.18K	0.04%	789
2022 Q1	$6.18M	Sell	634,898 -155	-0%	-$1.5K	0.05%	562
2021 Q4	$6.14M	Buy	+635,053	New	+$6.23M	0.06%	513

Other funds holding ORIA

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Cubist Systematic Strategies's ORIA Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q1 2023, closing a stake of 629,218 shares — an estimated $6.32M sold.

Cubist Systematic Strategies first reported a position in ORIA in Q4 2021 and held it in 5 quarters. The position peaked at $6.32M in Q4 2022. 49 funds tracked by Wall St. Rank hold ORIA as of Q1 2023.

Cubist Systematic Strategies reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 629,218 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q1 2023, an estimated $6.32M.
Cubist Systematic Strategies first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
Cubist Systematic Strategies's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $6.32M in Q4 2022.
49 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.